Question for the board I am an internist and have
Post# of 148261
I am an internist and have been long cydy since Feb.
Are any of you worried about miraviroc? They are in a p3 c19 trial and an oral ccr5 anatgonist
Are any of you worried about rlf100? Safe l, great eind data and interim analysis at the end of the month.
I guess are we still in play if these show decreased mortality prior to cydy?
Thoughts??